Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Photo: CNBCBiogen said signals suggest the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.
Why this matters for military families
Developments that affect daily life for service members and their families at duty stations worldwide.
Originally published by CNBC. Summary and curation by DutyStation.ai.